- Home
- NPO vs AXSM Comparison
NPO vs AXSM Comparison
Compare NPO & AXSM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NPO
- AXSM
- Stock Information
- Founded
- NPO 2002
- AXSM 2012
- Country
- NPO United States
- AXSM United States
- Employees
- NPO N/A
- AXSM N/A
- Industry
- NPO Metal Fabrications
- AXSM Biotechnology: Pharmaceutical Preparations
- Sector
- NPO Industrials
- AXSM Health Care
- Exchange
- NPO Nasdaq
- AXSM Nasdaq
- Market Cap
- NPO 3.9B
- AXSM 4.7B
- IPO Year
- NPO N/A
- AXSM 2015
- Fundamental
- Price
- NPO $174.93
- AXSM $90.73
- Analyst Decision
- NPO Buy
- AXSM Strong Buy
- Analyst Count
- NPO 2
- AXSM 14
- Target Price
- NPO $217.50
- AXSM $125.93
- AVG Volume (30 Days)
- NPO 151.7K
- AXSM 499.7K
- Earning Date
- NPO 02-18-2025
- AXSM 02-18-2025
- Dividend Yield
- NPO 0.69%
- AXSM N/A
- EPS Growth
- NPO N/A
- AXSM N/A
- EPS
- NPO 2.56
- AXSM N/A
- Revenue
- NPO $1,039,400,000.00
- AXSM $338,457,000.00
- Revenue This Year
- NPO N/A
- AXSM $44.89
- Revenue Next Year
- NPO $3.43
- AXSM $68.41
- P/E Ratio
- NPO $67.55
- AXSM N/A
- Revenue Growth
- NPO N/A
- AXSM 51.47
- 52 Week Low
- NPO $136.68
- AXSM $64.11
- 52 Week High
- NPO $197.94
- AXSM $105.00
- Technical
- Relative Strength Index (RSI)
- NPO 40.95
- AXSM 42.16
- Support Level
- NPO $188.86
- AXSM $89.09
- Resistance Level
- NPO $191.64
- AXSM $94.64
- Average True Range (ATR)
- NPO 4.56
- AXSM 3.64
- MACD
- NPO -3.19
- AXSM -1.14
- Stochastic Oscillator
- NPO 7.16
- AXSM 20.64
About NPO Enpro Inc.
Enpro Inc formerly EnPro Industries Inc is a United States-based company that designs, develops, manufactures, and markets proprietary engineered industrial products. The company operates through three segments: Sealing Technologies, which manufactures and markets sealing products, wheel-end components & systems, and Advanced Surface Technologies manufactures wafer processing sub-systems, thin-film coatings, optical filters, and other services like cleaning, coating, testing, and refurbishment. Its geographical segments are the United States, Europe, and other foreign countries.
About AXSM Axsome Therapeutics Inc.
Axsome Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapies for the management of the central nervous system, or CNS, disorders for which there are limited treatment options. Its pipeline products include AXS-05, AXS-07, AXS-12, and AXS-14. It manages its business as one operating segment and reporting unit, which is the business of developing and delivering novel therapies for the management of CNS disorders.